Trial intelligence / Profile preview

Long-term Safety of FlutiForm in Asthma

NCT00394121Phase 3Completed

Sponsor
Skyepharma
Start
Mar 2006
Primary completion
Jul 2007
Modality
Orthosteric Ligands
Countries
5
01

Overview

A Phase 3 trial of fluticasone propionate + formoterol in asthma, sponsored by Skyepharma. Started Mar 2006; status: completed.

02

Drugs

fluticasone propionate + formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00394121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00394121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call